Correlation Between Cingulate Warrants and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Inhibikase Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Inhibikase Therapeutics.
Diversification Opportunities for Cingulate Warrants and Inhibikase Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and Inhibikase is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Inhibikase Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 15.74 times more return on investment than Inhibikase Therapeutics. However, Cingulate Warrants is 15.74 times more volatile than Inhibikase Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 26.00 in Cingulate Warrants on September 4, 2024 and sell it today you would lose (21.15) from holding Cingulate Warrants or give up 81.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 74.75% |
| Values | Daily Returns |
Cingulate Warrants vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Inhibikase Therapeutics |
Cingulate Warrants and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Inhibikase Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
| Inhibikase Therapeutics vs. Candel Therapeutics | Inhibikase Therapeutics vs. Cingulate Warrants | Inhibikase Therapeutics vs. Unicycive Therapeutics | Inhibikase Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |